Multimodal High-frequency Ultrasound-based Study of Plaque Psoriasis Severity Index

Psoriasis (PsO) is a common chronic relapsing inflammatory disease, induced by a combination of genetic and environmental effects, which seriously affects the quality of life of patients.Psoriasis Area and Severity Index（PASI score ） ，as the most common method used by clinicians to assess the severity of psoriasis and the effectiveness of treatment, has the disadvantage of being subjective and superficial.We are therefore committed to establishing an objective, real-time, repeatable, non-invasive, microscopic assessment using high-frequency ultrasound. This study will use high-frequency ultrasound to detect the patient's lesion site and the 2cm site next to the lesion once, and the study will continue to recruit for 6 months.

NCT Number	NCT06579976
Lead Sponsor	Shanghai Yueyang Integrated Medicine Hospital
Conditions	Plaque Psoriasis
Enrollment	45 participants
Start Date	2024-09-01
Primary Completion	2025-02-28 (estimated)
Study Completion	2025-05-01 (estimated)
Updated on ClinicalTrials.gov	2024-08-30